19
Post-Event Post-Event Hypothermia Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Pane Sept 2004 DRAFT slides

Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Embed Size (px)

Citation preview

Page 1: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Post-Event HypothermiaPost-Event Hypothermia

Julie Swain M.D.

Cardiovascular SurgeonConsultant to the FDA

Circ System Devices Advisory PanelSept 2004

DRAFT slides

Page 2: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 2

Outline of Presentation

1. Post-event hypothermia in MI

2. Post-event hypothermia in head trauma

3. Post-event hypothermia in resuscitation

4. ILCOR recommendations

5. Questions for panel

Page 3: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 3

Post-Event Hypothermia in Myocardial Infarction

(Cool-MI Study)

• Data presented at TCT 2003(www.radiantmedical.com/download/TCT-ONeill.pdf)

• Prospective, randomized (cooling with IVC catheter vs normothermia during PCI)

• MI < 6 hrs, cool to 33°C for 3 hrs

• Quantitative Endpoint – infarct size at 30 days

Page 4: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 4

COOL-MI Study Results

13.8 % 14.1 %

0

10

20

30

control hypo T

% LVInfarctSize

N = 180 N = 177

p = N.S.

Data presented at TCT 2003(www.radiantmedical.com/download/TCT-ONeill.pdf

Page 5: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 5

COOL-MI Results

Complication Control

(n=180)

Hypo T (33°)

(n=177)

Death 2.2% 3.4%

Vascular/bleeding 15.6% 19.2%

DVT 0 1.7%

Shock 6.1% 12.4%

Pulm Edema 1.7% 3.4%

P = n.s. for all complications, not powered to assess MACE

Data presented at TCT 2003(www.radiantmedical.com/download/TCT-ONeill.pdf

Page 6: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 6

Post-Event Hypothermia in Brain Injury

(Clifton GL, et al. Lack of Effect of Induction of Hypothermia after Acute Brain Injury.  N Engl J Med 2001; 344: 556-63)

• Prospective, randomized, surface and GI cooling vs normothermia

• Injury < 6 hrs, cool to 33°C for 48 hrs• Endpoint – Glasgow Outcome Score at 6

months (functional independence with mild or moderate disability)

• Secondary endpoints of psychometric tests

Page 7: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 7

Secondary Endpoints in Brain Injury Trial (at 6 mos)

• Neurobehavioral Rating Scale – Revised• Disability Rating Scale• Galveston Orientation and Amnesia test• Selective Reminding Test• Rey-Osterrieth Complex Figure Test• Symbol Digit Modalities Test• Trail Making Test B• Controlled Oral Word Association Test• Grooved Pegboard Test

Page 8: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 8

Brain Injury Outcome

0

25

50

75

100

Control HypoT

% of PatientsPoor Outcome

N = 193 N = 199

p = N.S.

p = N.S. for all secondary endpoints

57% 57%

Page 9: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 9

Brain Injury Study Results

Complication Control

(n=193)

HypoT

(n=199)Critical Hypotension 3% 10%

Bradycardia w hypotension 4% 16% p = .04

% of hosp. days with complications

70% 78%

p = .01

p = .005

Page 10: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 10

Post-Event HypothermiaCardiac Arrest

• Bernard SA, et al.  Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia.  N Engl J Med 2002; 346:557-63 [Australia]

 • The Hypothermia After Cardiac Arrest Study

Group.  Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac Arrest.  N Engl J Med 2002; 346:549-56 [Europe]

Page 11: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 11

Comparison of Cardiac Arrest Studies

Location Australia Europe

# hypoT pts 43 136

Inclusion

Criteria

VF, return Spon Circ, coma, men>18 yrs, women >50 yrs

Witnessed arrest, VF, VT, cardiac origin, 18-75 yrs, 5-15 min to resuscitation by medical personnel, <60 min from arrest to restore circ ***

***91% of screened pts not eligible

Page 12: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 12

Comparison of Cardiac Arrest Studies

Australia Europe

When cooling started

In field Hospital admission

Cooling method Cold packs then ice packs

Air-cooled mattress, ice packs

Target Duration hypoT

12 hrs 24 hrs

Target Temp 33° 32-34°

Page 13: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 13

Comparison of Cardiac Arrest Studies

Australia Europe

Rewarming Active Passive

Adjunctive meds Midazolam

Vercuronium

Midazolam

Fentanyl

pancuronium

Page 14: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 14

Comparison of Cardiac Arrest Studies

Australia Europe

Primary

Endpoint

survival to hospital discharge with neuro function allowing home or rehabilitation

CPC good or moderate disability at 6 mos

Page 15: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 15

Comparison of Cardiac Arrest Studies

26%

49%

39%

55%

0

25

50

75

100

control hypo T control hypo T

% successendpoint

{Australia} {Europe}

p = .046

(***risk ratio 1.40, CI 1.08 – 1.81)

***

Page 16: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 16

Comparison of Cardiac Arrest Studies

68%

51% 55%

41%

0

25

50

75

100

control hypo T control hypo T

% mortality

{Australia}

{Europe}

***

(***risk ratio 0.74, CI .58 - .95)

p = N.S.

Page 17: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 17

ILCOR Recommendations(ILCOR Advisory Statement.  Therapeutic Hypothermia after

Cardiac Arrest.  Circulation 2003;108:18-21)

• Unconscious adult patients with spontaneous circulation after out-of-hospital cardiac arrest should be cooled to 32°C to 34°C for 12 to 24 hours when the initial rhythm was ventricular fibrillation (VF).

• Such cooling may also be beneficial for other rhythms or in-hospital cardiac arrest.

Page 18: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 18

Safety Profile of Cooling Methods• Surface

– Cool air– Water cooling– Head and neck cooling

• GI lavage

• Endovascular– Extracorporeal Circulation

• Cardiopulmonary Bypass• Veno-venous• Arterial venous

– IVC catheters

Page 19: Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides

Swain 19

Summary

• Is post-event hypothermia the standard for treating out-of-hospital arrest patients in the U.S.?

• Is surface-induced hypothermia comparable to endovascular hypothermia in safety and efficacy?